| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 5,850 | 6,100 | 20:11 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 22,200 | 30 | |||
| 19,600 | 2 | |||
| 16,000 | 500 | |||
| 15,000 | 15 | |||
| 6,750 | 71 | |||
| 6,650 | 71 | |||
| 6,550 | 71 | |||
| 6,100 | 1.886 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/88q.htm [/URL] | ||||
| 656 | 5,950 | |||
| 1.230 | 5,850 | |||
| 71 | 5,450 | |||
| 71 | 5,350 | |||
| 450 | 5,300 | |||
| 71 | 5,250 | |||
| 1.061 | 0,001 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 3.610 | 0,733 | 2.646 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
Keine Umsätze verfügbar. | ||
| Tagesumsatz Xetra | 0,000 0,00 % | 0 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 4BASEBIO Aktie jetzt für 0€ handeln | |||||
| 12.03. | IN BRIEF: 4basebio appoints Scott Lorimer as chief operating officer | 5 | Alliance News | ||
| 12.03. | 4basebio Plc - Appointment of COO | 339 | PR Newswire | 4basebio Plc - Appointment of COO
PR Newswire
LONDON, United Kingdom, March 12
THIS... ► Artikel lesen | |
| 09.03. | 4basebio promotes Christine Wolosin to chief commercial officer | 14 | Alliance News | ||
| 03.03. | 4basebio strengthens commercial leadership, promoting Christine Wolosin to Chief Commercial Officer | 237 | GlobeNewswire (Europe) | Seasoned biotechnology commercial leader will drive global growth strategy Commercial team further bolstered by promotions of James Vang and Jennifer Gelman to VP, Business Development and VP, Marketing... ► Artikel lesen | |
| 03.03. | 4basebio Plc - Appointment of CCO | 263 | PR Newswire | 4basebio Plc - Appointment of CCO
PR Newswire
LONDON, United Kingdom, March 03
THIS... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 15:03 | EQS-News: Wall Street Wire: Verteidigungsboom trifft Biotech - MediWound könnte zu den unterschätzten Profiteuren zählen (NASDAQ: MDWD) | EQS Group (DE) | EQS-News: Wall Street Wire
/ Schlagwort(e): Sonstiges
Verteidigungsboom trifft Biotech - MediWound könnte zu den unterschätzten Profiteuren zählen (NASDAQ: MDWD)
26.03.2026... ► Artikel lesen | |
| 15:50 | BioInvent International: BioInvent Achieves Phase 3 Milestone for HMI-115 in Endometriosis | ACCESS Newswire | BioInvent International (STO:BINV) - Achievement of the milestone triggers a payment of € 1 million LUND, SE / ACCESS Newswire / March 26, 2026 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV)... ► Artikel lesen | |
| 17:00 | NurExone stellt Weichen für Wachstum und Sichtbarkeit | Small- & Micro Cap Investment | ||
| 18:06 | EIB Waives its Right to Cash Settlement on Medincell Warrants | Business Wire | The European Investment Bank (EIB) has waived the put option attached to the warrants granted in connection with the €40 million financing agreement signed in 2022 This waiver eliminates any... ► Artikel lesen | |
| 15:10 | ViroGates A/S: ViroGates announces its Annual Report 2025: Revenue growth and improved operating result as strategic transition towards preventive health and longevity continues | GlobeNewswire (Europe) | Company Announcement no. 1/2026 (March 26, 2026 at 15:10:00 CET)
Inside information
BIRKERØD, DENMARK ViroGates A/S ("ViroGates" or "Company"), a medical technology company developing blood tests for... ► Artikel lesen |